Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 22 Suppl 1, S43-8

Attention-deficit/hyperactivity Disorder (ADHD)

Affiliations
Review

Attention-deficit/hyperactivity Disorder (ADHD)

Søren Dalsgaard. Eur Child Adolesc Psychiatry.

Abstract

The proposed revision of the diagnostic criteria in DSM-5 for attention-deficit/hyperactivity disorder (ADHD) will not fundamentally change the concept of ADHD. This is mainly due to the fact that, DSM-5 will retain the exact DSM-IV wording of all 18 symptoms, but will add new examples that make the criteria more appropriate for children, adolescents and adults. The age of onset will also be changed from 7 to 12 years, the subtyping of the disorder will change, and pervasive developmental disorders will no longer be an exclusion criterion. Although the main concept is unchanged, the suggested changes will most likely increase the prevalence of ADHD, especially in adults and adolescents, but maybe also in children. The added examples will also result in necessary revisions and new validations of rating scales and diagnostic interviews. This review will examine each of the proposed DSM-5 changes and the impact they may have, and in addition, the paper will make an overview of the main characteristics of some of the international and national guidelines for assessment and treatment of ADHD and how these impact the clinical practice.

Similar articles

See all similar articles

Cited by 7 PubMed Central articles

See all "Cited by" articles

References

    1. CNS Spectr. 2008 Nov;13(11):977-84 - PubMed
    1. MMW Fortschr Med. 2007 May 21;149 Suppl 2:10-3; quiz 14 - PubMed
    1. Annu Rev Med. 2002;53:113-31 - PubMed
    1. J Am Acad Child Adolesc Psychiatry. 2010 Mar;49(3):210-6 - PubMed
    1. Am J Psychiatry. 2006 Apr;163(4):716-23 - PubMed

MeSH terms

LinkOut - more resources

Feedback